期刊文献+

ST段抬高心肌梗死溶栓治疗的时机与预后 被引量:4

Opportunity and prognosis of thrombolytic treatment of ST-segment elevation myocardial infarction
在线阅读 下载PDF
导出
摘要 目的:观察ST段抬高心肌梗死(STEMI)患者溶栓治疗时机与预后的关系。方法纳入2008年7月~2012年6月广东省吴川市人民医院STEMI患者229例,所有患者均采用溶栓治疗。根据患者发病至溶栓时间,分为4个治疗时间段,发病至溶栓<3h为第1组(n=67),(3~6)h为第2组(n=96),(6~12)h为第3组(n=45),(12~24)h为第4组(n=21)。观察各组溶栓再通率(包括胸痛缓解、心电图ST段回落和心肌酶CK-MB峰值提前)以及30天内全因死亡率。结果随着发病至溶栓时间的延长,溶栓再通率不断下降[第1组:82.09%(55/67),第2组:73.96%(71/96),第3组:42.22%(19/45),第4组:35.00%(7/20)],30天死亡率不断升高[第1组:5.97%(4/67);第2组:9.38%(9/96);第3组:11.11%(5/45),第4组:15.00%(3/20)],各组之间均有统计学差异(P<0.05)。结论溶栓治疗时机越早则患者预后越好,超过12小时的患者仍可进行溶栓治疗,并能够改善预后。 Objective To observe the relationship between opportunity and prognosis of thrombolytic treatment of ST-segment elevation myocardial infarction (STEMI).Methods The patients diagnosed as STEMI (n=229) were chosen from People’s Hospital of Wuchuan City of Guangdong Province from Jul. 2008 to Jun. 2012. All patients were given thrombolytic treatment, and the treatment time was divided into 4 groups according to the periods from disease onset time to thrombolytic time. The period less than 3 h was taken as group 1 (n=67), (3-6) h as group 2 (n=96), (6-12) h as group 3 (n=45) and (12-24) h as group 4 (n=21). The recanalization rate (including chest pain relieving, ST-segment falling back and peak of myocardial enzyme CK-MB advancing) and all-cause mortality within 30 d were observed in all groups.Results As the prolong of the periods from disease onset time to thrombolytic time, recanalization rate decreased continuously [group 1: 82.09% (55/67), group 2: 73.96% (71/96), group 3: 42.22% (19/45) and group 4: 35.00% (7/20)], and all-cause mortality within 30 d increased continuously [group 1: 5.97% (4/67), group 2: 9.38% (9/96), group 3: 11.11% (5/45) and group 4: 15.00% (3/20)]. There was statistical difference among all groups (P〈0.05).Conclusion If the time of thrombolytic treatment is earlier, the prognosis will be better in the patients with STEMI. The patients with disease onset time over 12 h still can be given thrombolytic treatment and the prognosis can be improved.
出处 《中国循证心血管医学杂志》 2013年第6期608-610,共3页 Chinese Journal of Evidence-Based Cardiovascular Medicine
关键词 ST段抬高型心肌梗死 时机 溶栓治疗 临床疗效 预后 ST-segment elevation myocardial infarction Opportunity Thrombolytic treatment Curative effect Prognosis
  • 相关文献

参考文献9

二级参考文献13

共引文献2010

同被引文献28

  • 1Niccoli G,Burzotta F,Galiuto L,et al. Myocardial no-reflow in humans[J]. J AM Cardiol,2009, 54(4):281-92.
  • 2Kim JS,Kim J,Choi D,et al. Efficacy of high-dose atorvastatin loading before primary peutaneous coronary intervention in ST-segment elevation myocardial infarction:the STATIN STEMI trial[J]. JACC Cardiovasc Interv,2010,3(3):332-9.
  • 3rhygesen K,Alpert JS,Jaffe AS,et al. Third universal definition of myocardial infarction[J]. Nat Rev Cardiol,2012,9(11),620-33.
  • 4Levine GN,Bates ER,Blankenship JC,et al. 2011 ACCF/AHA/ 5CAI guideline for percutaneous coronary intervention[J]. Circulation,2011,124(23):e574-651.
  • 5Steg PG,Jame SK,Atar D,et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation[J]. Eur Heart J,2012, 33(20):2569-619.
  • 6Vrints C J. Pathophysiology of the no-reflow phenomenon[J]. Acute Card Care,2009, 11(2):69-76.
  • 7Di Sciascio G,Patti G,Pasceri V,et al. Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneus coronary intervention : results of the ARMYDA-RECAPTURE Randomized Trail[J]. J Am Coil Cardiol,2009,54(6):558-65.
  • 8余静,李旭.CT冠状动脉成像在冠心病诊断中的应用[J].西北国防医学杂志,2012,33(5):527-529. 被引量:9
  • 9张纪梅.尿激酶溶栓治疗发病2h内急性ST段抬高型心肌梗死的疗效[J].中国老年学杂志,2013,33(1):170-171. 被引量:53
  • 10冯汀兰,赵宇芳.溶栓时机对急性心肌梗死溶栓效果的影响[J].中西医结合心脑血管病杂志,2013,11(2):235-236. 被引量:21

引证文献4

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部